60 Degrees Pharmaceuticals Inc. (SXTP) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    60 Degrees Pharmaceutical...

    NASDAQ: SXTP · Real-Time Price · USD
    1.40
    -0.04 (-2.64%)
    At close: Oct 03, 2025, 3:59 PM
    1.42
    1.43%
    After-hours: Oct 03, 2025, 04:38 PM EDT

    60 Degrees Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.37 -64.36 -262.63 -381.85
    PEG Ratio
    		 -0.00 5.74 -5.89 -9.03
    PS Ratio
    		 4.30 955.82 7.27K 1.4K
    PB Ratio
    		 0.73 49.77 -68.86 -92.36
    P/FCF Ratio
    		 -0.5 -52.02 -1.52K -2.37K
    P/OCF Ratio
    		 -0.52 -53.35 -1.61K -2.5K
    OCF/S Ratio
    		 -8.29 -17.92 -4.52 -0.56
    Debt / Equity Ratio
    		 0.04 0.04 -0.95 -1.07
    Quick Ratio
    		 2.98 2.39 0.02 0.77
    Current Ratio
    		 3.25 2.55 0.05 1.85
    Asset Turnover
    		 0.12 0.03 0.17 0.83
    Interest Coverage
    		 -1.23K -2.25 -0.44 -0.35
    Return on Equity
    		 -1.97 -0.77 0.26 0.24
    Return on Assets
    		 -1.38 -0.48 -4.77 -3.05
    Return on Invested Capital
    		 -2.36 -1.04 1.37 -1.25
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.33 -0.87 -0.94 0.27
    Net Profit Margin
    		 -11.66 -14.85 -27.69 -3.66
    Pretax Profit Margin
    		 -11.68 -15.04 -27.68 -3.67
    Operating Profit Margin
    		 -14.26 -20.33 -7.84 -0.97
    FCF Margin
    		 -8.56 -18.37 -4.79 -0.59
    EBITDA Margin
    		 -11.57 -5.63 -9.45 -0.87

    Add to Watchlist